We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lemierre's Syndrome Bacteria Are Responsible for Many Cases of Sore Throat Among Adolescents in the US

By LabMedica International staff writers
Posted on 23 Feb 2015
A recent study conducted at a student health clinic in the United States found that more cases of severe sore throat (pharyngitis) among young adults were caused by the bacterium Fusobacterium necrophorum than by hemolytic streptococci or by Mycoplasma pneumoniae.

The anaerobic bacterium F. More...
necrophorum was shown in European studies to account for about 10% of sore throats and was the primary cause of Lemierre's syndrome.

Lemierre's syndrome develops most often after a sore throat caused by some bacterium of the Streptococcus genus has created a peritonsillar abscess, a pocket filled with pus and bacteria near the tonsils. Deep in the abscess, anaerobic bacteria like F. necrophorum can flourish. The bacteria penetrate from the abscess into the neighboring jugular vein in the neck and there they cause an infected clot to form, from which bacteria are seeded throughout the body by the bloodstream. Bits of the infected clot break off and travel to the lungs as emboli where they block branches of the pulmonary artery bringing deoxygenated blood from the heart to the lungs. This causes shortness of breath, chest pain, and severe pneumonia. The syndrome affects mostly adolescents and young adults and is seen rarely in pre-adolescents. It often causes long, complex hospitalizations requiring intensive care, and although the organism is usually sensitive to penicillin and other antibiotics, about 6% of those contracting Lemierre’s syndrome die.

As there is little available data regarding F. necrophorum infection in the US, investigators at the University of Alabama (Birmingham, USA) used an in-house PCR assay to identify four different pathogenic microorganisms in throat swabs from 312 students aged 15 to 30 years presenting to a student health clinic with an acute sore throat and 180 asymptomatic students.

Results revealed that F. necrophorum was detected in 20.5% of patients and 9.4% of asymptomatic students. Group A beta-hemolytic Streptococcus was detected in 10.3% of patients and 1.1% of asymptomatic students. Group C/G beta-hemolytic Streptococcus was detected in 9.0% of patients and 3.9% of asymptomatic students. Mycoplasma pneumoniae was detected in 1.9% of patients and none of the asymptomatic students.

“This is the first study in the United States that shows that F. necrophorum causes a significant number of cases of pharyngitis in this young adult population,” said first author Dr. Robert M. Centor, professor of general internal medicine at the University of Alabama. “It is also the first to show that F. necrophorum pharyngitis and Streptococcus pharyngitis share similar clinical signs. This study bolsters our understanding that this condition is common in the US and very closely resembles strep throat.”

“It is not just about strep throat in this 15–30 age group,” said Dr. Centor. “Physicians have to consider F. necrophorum, which in our study caused more sore throats than strep. And, F. necrophorum is itself associated with a potentially devastating complication, which while rare, is a more common side effect that acute rheumatic fever. This is the first step in a series of studies that need to be done to define the prevalence and extent of F. necrophorum and how it presents clinically. A very important next step is to develop a practical and affordable point-of-care test for F. necrophorum.

The study was published in the February 17, 2015, online edition of the journal Annals of Internal Medicine.

Related Links:
University of Alabama



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
New
Sample Transportation System
Tempus1800 Necto
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Over 100 new epigenetic biomarkers may help predict cardiovascular disease risk (Photo courtesy of 123RF)

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk

Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.